manage Diabetes with a workout regime

How to manage Diabetes with a workout regime

According to research, regular exercise enhances blood glucose control, delays or prevents the onset of type 2 diabetes, and increases your body’s sensitivity to insulin, which combats insulin resistance. In New Delhi, regular exercise or physical activity is a crucial component of managing type 2 diabetes. Studies demonstrating the value of exercise in managing diabetes […]

Continue Reading
A cup of tea to beat Diabetes?

A cup of tea to beat Diabetes?

To clarify the connection between tea consumption and the risk of developing type 2 diabetes in the future, researchers carried out a cohort study and a dose-response meta-analysis. Washington: A study involving more than a million people from eight nations found that drinking black, green, or oolong tea in moderation is associated with a lower […]

Continue Reading
Pandemic may have affected children's behavior

Experts: Pandemic may have affected children’s behavior in more than one way

Kolkata: According to developmental paediatricians who attended a two-day meeting in the city over the weekend, there has been a significant increase in the number of kids with developmental and behavioural disorders across cities, including Kolkata, during Covid, which has led to a rush for treatment over the last eight months. They noted that due […]

Continue Reading
Tight Blood Sugar Control

“Tight Blood Sugar Control” Boosts Brain Power of Teens With Type 1 Diabetes: Study

 A recent clinical experiment suggests that teens with type 1 diabetes may have cognitive benefits when their blood sugar levels are better managed. Teenagers were better able to avoid high blood sugar episodes when they began therapy using newer technology, commonly referred to as “artificial pancreas” devices, than teens who continued with conventional diabetes treatment. […]

Continue Reading
Essential diabetes drugs' prices

Essential diabetes drugs’ prices are constrained by a pricing authority

Two essential anti-diabetic medications—Sitagliptin-Metformin combination and Linagliptin-Metformin combination—have been placed under price control by India’s drug pricing authority. The National Pharmaceutical Pricing Authority has set retail prices for 45 drug formulations, including the two anti-diabetic medications (NPPA). Since Merck Sharp and Dohme’s (MSD) Sitagliptin patent expired last month, several generic versions of the drug have […]

Continue Reading